Published in Toxicol Appl Pharmacol on March 01, 1977
Histopathology and cytotoxicity as biomarkers in treated rats with cadmium and some therapeutic agents. Saudi J Biol Sci (2013) 0.78
Rapid extraction method with pronase B for grouping beta-hemolytic streptococci. Appl Microbiol (1972) 4.61
A rapid micromethod for determination of FMN and FAD in mixtures. Anal Biochem (1973) 2.19
Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J (1992) 1.67
Isolation and partial characterization of a cadmium-binding protein from the American oyster (Crassostrea virginica). Chem Biol Interact (1979) 1.43
Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology (1997) 1.28
TCDD-induced changes in rat liver microsomal enzymes. Environ Health Perspect (1973) 1.24
Human pulmonary pasteurellosis. JAMA (1979) 1.17
Atomic absorption determination of cadmium and lead in whole blood by a reagent-free method. Anal Chem (1972) 1.16
Ultrastructural and biochemical effects of prolonged oral arsenic exposure on liver mitochondria of rats. Environ Health Perspect (1977) 1.12
Occupational lead exposure, nephropathy, and renal cancer. Am J Ind Med (1980) 1.12
Arsine poisoning. N Engl J Med (1974) 1.09
Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis (1997) 1.09
An outbreak of syphilis on an Indian reservation: descriptive epidemiology and disease-control measures. Am J Public Health (1989) 1.08
Early cellular effects of circulating cadmium-thionein on kidney proximal tubules. Environ Health Perspect (1979) 1.07
Effects of arsenic on pyruvate dehydrogenase activation. Environ Health Perspect (1977) 1.06
Mercury uptake by renal lysosomes of rats ingesting methyl mercury hydroxide. Ultrastructural observations and energy dispersive x-ray analysis. Arch Pathol (1974) 1.05
Trace elements in hair, as related to exposure in metropolitan New York. Clin Chem (1975) 1.04
The morphological effects of chronic cadmium administration on the renal vasculature of rats given low and normal calcium diets. Toxicol Appl Pharmacol (1975) 1.03
Choosing a medical specialty: a critique of literature in the light of "curious findings". J Health Soc Behav (1975) 1.02
Mechanisms of nephrotoxicity from metal combinations: a review. Drug Chem Toxicol (2000) 1.00
High-affinity lead binding proteins in rat kidney cytosol mediate cell-free nuclear translocation of lead. J Pharmacol Exp Ther (1985) 0.99
Intracellular binding of lead in the kidney: the partial isolation and characterization of postmitochondrial lead binding components. Biochem Biophys Res Commun (1982) 0.96
Effects of lead on the heme biosynthetic pathway in rat kidney. Exp Mol Pathol (1985) 0.96
Purification and characterization studies of cadmium-binding proteins from the American oyster, Crassostrea virginica. Environ Health Perspect (1986) 0.95
Isolation and partial characterization of a high molecular weight Cd/Zn-binding protein from the kidney of the scallop Placopecten magellanicus: preliminary studies. Environ Health Perspect (1986) 0.95
Alteration in protein synthesis in primary cultures of rat kidney proximal tubule epithelial cells by exposure to gallium, indium, and arsenite. Toxicol Appl Pharmacol (1990) 0.95
Pollutant burdens and biological response. Arch Environ Health (1973) 0.95
The effects of chronic oral methyl mercury exposure on the lysosome system of rat kidney. Morphometric and biochemical studies. Lab Invest (1975) 0.95
Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney. Toxicol Appl Pharmacol (1980) 0.95
Intracellular compartmentation of metals in aquatic organisms: roles in mechanisms of cell injury. Environ Health Perspect (1987) 0.95
In vivo X-ray fluorescence of lead in bone. Environ Res (1992) 0.94
The transplacental toxicity of methyl mercury to fetal rat liver mitochondria. Morphometric and biochemical studies. Lab Invest (1977) 0.94
Effects of chronic arsenic exposure on hematopoietic function in adult mammalian liver. Environ Health Perspect (1977) 0.94
Arthroscopic surgery of the knee under local anesthesia. Arthroscopy (1990) 0.94
Ultrastructural and biochemical changes in renal mitochondria during chronic oral methyl mercury exposure: the relationship to renal function. Exp Mol Pathol (1977) 0.93
The morphologic effects of dieldrin and methyl mercuric chloride on pars recta segments of rat kidney proximal tubules. Am J Pathol (1972) 0.93
Influence of metal ions on renal cytosolic lead-binding proteins and nuclear uptake of lead in the kidney. Biochem Pharmacol (1986) 0.93
Transfer RNA methylase inhibitors in neoplastic and normal rat tissue. Biochem Biophys Res Commun (1970) 0.92
The renal toxicity of cadmium metallothionein: morphometric and X-ray microanalytical studies. Toxicol Appl Pharmacol (1978) 0.92
Mechanism of renal lead-binding protein reversal of delta-aminolevulinic acid dehydratase inhibition by lead. J Pharmacol Exp Ther (1985) 0.91
Kinetic studies of tryptophan synthetase. Interaction of substrates with the B subunit. Biochemistry (1970) 0.91
Ruthenium red staining of rat glomerulus. Perfusion of ruthenium red into normal and nephrotic rat kidney. Histochemie (1970) 0.91
Bioassay-directed fractionation of 1-nitropyrene metabolites: generation of mutagrams by coupling reverse-phase HPLC with microsuspension mutagenicity assays. Mutagenesis (1990) 0.91
Bismuth localization within nuclear inclusions by x-ray microanalysis. Effects of accelerating voltage. J Histochem Cytochem (1975) 0.91
Nicotinamide: a natural inhibitor of tRNA methylase. Biochem Biophys Res Commun (1971) 0.90
Studies on the action of porphyrinogenic trace metals on the activity of hepatic uroporphyrinogen decarboxylase. Biochem Biophys Res Commun (1981) 0.90
Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat. J Lab Clin Med (1981) 0.89
Alteration of hepatic microsomal structure and function by indium chloride. Ultrastructural, morphometric, and biochemical studies. Lab Invest (1983) 0.89
Ultrastructural evidence for nephropathy induced by long-term exposure tosmall amounts of methyl mercury. Science (1972) 0.89
Chicken parathyroid hormone-related protein and its expression during embryologic development. J Bone Miner Res (1991) 0.89
Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein. J Pharmacol Exp Ther (1984) 0.89
Introduction and summary. International workshop on lead in bone: implications for dosimetry and toxicology. Environ Health Perspect (1991) 0.89
Factors influencing cadmium accumulation and its toxicity to marine organisms. Environ Health Perspect (1979) 0.88
Constrictive pericarditis, intestinal lymphangiectasia, and reversible immunologic deficiency. J Pediatr (1975) 0.88
Mercury concentrations in fish from Lake Mead, USA, related to fish size, condition, trophic level, location, and consumption risk. Arch Environ Contam Toxicol (2002) 0.88
Rational approaches to chemotherapy: antisickling agents. Science (1981) 0.87
CT-integrated robot for interventional procedures: preliminary experiment and computer-human interfaces. Comput Aided Surg (2001) 0.87
Binding of 1-nitro[14C]pyrene to DNA and protein in cultured lung macrophages and respiratory tissues. Cancer Lett (1983) 0.87
High-affinity renal lead-binding proteins in environmentally-exposed humans. Chem Biol Interact (1998) 0.87
Kinetic studies of tryptophan synthetase. Interaction of L-serine, indole, and tryptophan with the native enzyme. Biochemistry (1971) 0.87
Evaluation of the release of mutagens from diesel particles in the presence of physiological fluids. Environ Mutagen (1981) 0.87
Epidemiology of tuberculosis in North Carolina, 1966 to 1986: analysis of demographic features, geographic variation, AIDS, migrant workers, and site of infection. South Med J (1989) 0.87
Renal porphyrinuria during chronic methyl mercury exposure. J Lab Clin Med (1977) 0.86
Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding. J Pharmacol Exp Ther (1984) 0.86
Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp47 production in osteoblast-like ROS 17/2.8 cells. Toxicol Appl Pharmacol (1992) 0.86
Alteration of hepatocellular structure and function by thallium chloride: ultrastructural, morphometric, and biochemical studies. Toxicol Appl Pharmacol (1986) 0.86
Calculation of distorted circular dichroism curves for poly-L-glutamic acid suspensions. Arch Biochem Biophys (1970) 0.85
A low molecular weight lead-binding protein in brain attenuates lead inhibition of delta-aminolevulinic acid dehydratase: comparison with a renal lead-binding protein. J Pharmacol Exp Ther (1986) 0.85
Interactions among lead, cadmium, and arsenic in relation to porphyrin excretion patterns. Environ Health Perspect (1978) 0.85
Effects of separate and combined chronic mercuric chloride and sodium selenate administration in rats: histological, ultrastructural, and x-ray microanalytical studies of liver and kidney. J Environ Pathol Toxicol (1979) 0.85
Long-term turnover of cadmium metallothionein in liver and kidney following a single low dose of cadmium in rats. Biochim Biophys Acta (1981) 0.85
Effects of concurrent administration of lead, cadmium, and arsenic in the rat. Environ Health Perspect (1977) 0.85
Polychlorinated biphenyls in the blood of personnel from an electric utility. J Occup Med (1985) 0.85
Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain. Biochem Biophys Res Commun (1989) 0.84
Flavin interaction in NADPH-sulfite reductase. Z Naturforsch B (1972) 0.84
Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. IV. Current information on interpreting the health implications of tests. Ren Fail (1997) 0.84
Production of low molecular weight cadmium-binding proteins in rabbit lung following exposure to cadmium chloride. Biochem Pharmacol (1982) 0.84
Regulatory roles of high-affinity metal-binding proteins in mediating lead effects on delta-aminolevulinic acid dehydratase. Ann N Y Acad Sci (1987) 0.83
Renal metabolism and toxicity of metallothionein. Dev Toxicol Environ Sci (1982) 0.83
Effects of the herbicide paraquat on the ultrastructure of mouse kidney. Am J Pathol (1971) 0.83
Evidence for oxidative damage to red blood cells in mice induced by arsine gas. Toxicology (1990) 0.82
Ultrastructural changes in rat liver cells following a single oral dose of TCDD. Environ Health Perspect (1973) 0.82
Evaluation of the release of mutagens and 1-nitropyrene from diesel particles in the presence of lung macrophages in culture. Environ Mutagen (1983) 0.81
The effects of acute and subacute sodium arsenite administration on carbohydrate metabolism. Toxicol Appl Pharmacol (1980) 0.81
Effect of intratracheal gallium arsenide administration on delta-aminolevulinic acid dehydratase in rats: relationship to urinary excretion of aminolevulinic acid. Toxicol Appl Pharmacol (1988) 0.81
Kidney zinc-thionein regulation of delta-aminolevulinic acid dehydratase inhibition by lead. Arch Biochem Biophys (1987) 0.81
Lead-binding proteins in brain tissue of environmentally lead-exposed humans. Chem Biol Interact (1995) 0.81
Observations on the preparation of epoxy embedded tissue samples for energy-dispersive x-ray analysis. Stain Technol (1973) 0.81
Lipid and carbohydrate metabolic risk markers for coronary heart disease and blood pressure in healthy non-obese premenopausal women of different racial origins in the United Kingdom. Metabolism (1996) 0.80
Arsine: absence of developmental toxicity in rats and mice. Fundam Appl Toxicol (1990) 0.80
Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts. Carcinogenesis (1997) 0.80
Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants--metals. SAR QSAR Environ Res (2010) 0.80
Metal alteration of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase. Ann N Y Acad Sci (1987) 0.80
General subcellular effects of lead, mercury, cadmium, and arsenic. Environ Health Perspect (1978) 0.80
Prolonged deterioration of ischemic brain energy metabolism and acidosis associated with hyperglycemia: human cerebral infarction studied by serial 31P NMR spectroscopy. Ann Neurol (1988) 0.80
The in vivo measurement of bone lead stores by 109Cd K X-ray fluorescence in a non-human primate (Macaca mulatta). Basic Life Sci (1993) 0.79
Metal constitution of metallothionein influences inhibition of delta-aminolaevulinic acid dehydratase (porphobilinogen synthase) by lead. Biochem J (1987) 0.79
Mutagenicity of 1-nitropyrene metabolites from lung S9. Cancer Lett (1984) 0.79
Acylation of hemoglobin by succinyldisalicylate, a potential crosslinking reagent. Biochem Biophys Res Commun (1975) 0.79